An Evaluation of Patient Reported Outcomes and Clinical Outcomes
NCT ID: NCT06092970
Last Updated: 2025-08-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
379 participants
OBSERVATIONAL
2023-10-16
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Patient reported outcomes (PRO), using the EQ-5D questionnaire
* Clinical outcomes
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of RBT-1 on Reducing the Risk of Post-Operative Complications in Subjects Undergoing Cardiac Surgery
NCT06021457
Retrospective Observational Study of Patients Who Have Undergone Coronary Artery Bypass Graft (CABG) and/or Cardiac Valve Surgery
NCT07009340
Effect of RBT-1 on Preconditioning Response Biomarkers in Subjects Undergoing CABG and/or Cardiac Valve Surgery
NCT04564833
A Study to Evaluate RMC-035 in Subjects Undergoing Cardiac Surgery
NCT04829916
Quality Measurement and Improvement Study of Surgical Coronary Revascularization: Secondary Prevention
NCT02430012
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
RBT-1
Patients undergoing CABG, valve, or combined CABG/valve surgery
RBT-1
Intravenous administration
Placebo
Patients undergoing CABG, valve, or combined CABG/valve surgery
Placebo
Intravenous administration
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
RBT-1
Intravenous administration
Placebo
Intravenous administration
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Female subjects who become pregnant during the REN-007 study are not eligible to participate in the Extension Study.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Renibus Therapeutics, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Huntsville, Alabama, United States
Research Site
San Francisco, California, United States
Research Site
Stanford, California, United States
Research Site
Washington D.C., District of Columbia, United States
Research Site
Atlantis, Florida, United States
Research Site
Gainesville, Florida, United States
Research Site
Athens, Georgia, United States
Research Site
Atlanta, Georgia, United States
Research Site
Fort Wayne, Indiana, United States
Research Site
Indianapolis, Indiana, United States
Research Site
Indianapolis, Indiana, United States
Research Site
Kansas City, Kansas, United States
Research Site
Boston, Massachusetts, United States
Research Site
Ann Arbor, Michigan, United States
Research Site
Lansing, Michigan, United States
Research Site
Midland, Michigan, United States
Research Site
Royal Oak, Michigan, United States
Research Site
Rochester, Minnesota, United States
Research Site
St Louis, Missouri, United States
New York Presbyterian-Queens
Flushing, New York, United States
Research Site
Raleigh, North Carolina, United States
Research Site
Winston-Salem, North Carolina, United States
Research Site
Cleveland, Ohio, United States
Research Site
Toledo, Ohio, United States
Research Site
Nashville, Tennessee, United States
Research Site
Dallas, Texas, United States
Research Site
Houston, Texas, United States
Research Site
San Antonio, Texas, United States
Research Site
Charlottesville, Virginia, United States
Research Site
Kelowna, British Columbia, Canada
Research Site
Saint John, New Brunswick, Canada
Research Site
St. John's, Newfoundland and Labrador, Canada
Research Site
Hamilton, Ontario, Canada
Research Site
Kingston, Ontario, Canada
Research Site
Montreal, Quebec, Canada
Research Site
Montreal, Quebec, Canada
Research Site
Montreal, Quebec, Canada
Research Site
Montreal, Quebec, Canada
Research Site
Québec, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REN-007E
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.